Antiemetic Control with Palonosetron in Patients with Gastrointestinal Cancer Receiving a Fluoropyrimidine-Based Regimen in Addition to Either Irinotecan or Oxaliplatin: A Retrospective Study
Oncology, 07/18/2012
Clinical Article
Blazer M et al. – The addition of palonosetron (PALO) may provide increased control of chemotherapy–induced nausea and vomiting (CINV) for the moderately emetogenic regimens of oxaliplatin or irinotecan plus a fluoropyrimidine in gastrointestinal (GI) cancer patients.



